Skip to main content
. 2023 Mar 24;11:1098419. doi: 10.3389/fpubh.2023.1098419

Figure 2.

Figure 2

Modeled expected global number of paralytic cVDPV2 cases by year for 100 stochastic iterations of the different vaccine choices and oSIA characteristics for the period 2016–2026. The figure legend shows outbreak vaccine choice and response characteristics. The panel on the left shows results for modeled scenarios in which IPV is used in RI in all countries as a prerequisite to OPV cessation. The panel on the right shows results for modeled scenarios in which there is no prerequisite for introduction of IPV into RI in countries classified as low-income or lower middle-income by the World Bank.